The remaining variables to be assessed for subsequent stage were as follows: age, BMI, gravidity, parity, gestational age, placental orientation, delivery indication, primary (pre-labor) Hb, primary platelet count, serum fibrinogen, GDM, hypertension, suppository progesterone use throughout the pregnancy. This evidence concerns the gene GSTM1 and gestational diabetes.